GTCR Recapitalizes Cole-Parmer with Golden Gate Capital and Management

Cole-Parmer (GTCR Portfolio) Acquires ZeptoMetrix

January 12, 2021

Biotechnology

GTCR’s portfolio company Cole-Parmer has acquired ZeptoMetrix, a Buffalo-based developer and manufacturer of quality control standards and verification panels for molecular diagnostic testing. The acquisition expands Cole-Parmer’s life sciences quality controls and reference standards portfolio and strengthens its capabilities in infectious disease and molecular diagnostics.

Kohlberg & Company Recapitalizes Trinity Life Sciences

November 30, 2021

Healthcare Services

Kohlberg & Company will recapitalize Trinity Life Sciences, replacing Parthenon Capital as the company’s capital partner. The transaction provides Trinity with new growth capital to support global expansion, technology and data-driven capability investments while Trinity’s management team, led by CEO David Fitzhenry, will remain in place.

GTCR Invests in Biocoat

November 2, 2022

Medical Devices

GTCR has made a strategic, majority recapitalization investment in Biocoat Holdings, LLC, a Horsham, Pennsylvania-based provider of biocompatible hydrophilic coatings and dip-coating equipment for medical devices. Existing investor 1315 Capital and Biocoat management retain minority stakes; GTCR will partner with CEO Jim Moran and add industry veteran Chip Hance as Executive Chairman to support growth, capability expansion and follow-on acquisitions.

Golden Gate Capital Recapitalizes Parallel Advisors; Parallel Acquires AUTUS Asset Management

January 5, 2023

Wealth Management

Parallel Advisors completed a recapitalization led by its management team and Golden Gate Capital to accelerate organic growth and M&A. In connection with the investment, Parallel acquired AUTUS Asset Management, bringing the combined firm to approximately $5.7 billion in AUM, and prior minority investor Emigrant Partners fully exited.

Golden Gate Capital Acquires Majority Stake in Ensemble Health Partners

May 29, 2019

Healthcare Services

Golden Gate Capital has acquired a 51% equity stake in Ensemble Health Partners from Bon Secours Mercy Health, with Bon Secours remaining a minority owner and commercial partner. Ensemble, headquartered in Mason, Ohio, will continue to be led by its existing management team and will use the investment to expand technology, services and growth initiatives across its revenue cycle management operations (the company has ~3,600 employees).

GTCR Invests $1.33 Billion in Tricentis

November 26, 2024

Software

GTCR has signed a definitive agreement to invest $1.33 billion in Tricentis, valuing the enterprise at $4.5 billion. Insight Partners will continue as a significant investor and will work with GTCR with equal board representation as Tricentis uses the capital to fuel growth, product innovation, and global expansion.